Results 11 to 20 of about 10,708 (185)
Paraneoplastic neurological syndromes: clinical presentations and management
Therapeutic Advances in Neurological Disorders, 2021 We provide an overview of the varied presentations of paraneoplastic neurological syndromes. We also review the onconeural antibodies and their particular oncological and neurological associations.
Michelle F. Devine +3 more
doaj +1 more source
Frontiers in Neurology, 2021 Paraneoplastic neurological syndromes are more commonly seen with malignancies such as small cell lung cancer, thymoma, gynecological malignancies, and breast cancer as well as seminoma.
Cristina Valencia-Sanchez +1 more
doaj +1 more source
‘Medusa-head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII [PDF]
, 2015 Serological testing for anti-neural autoantibodies is important in patients presenting with idiopathic cerebellar ataxia, since these autoantibodies may indicate cancer, determine treatment and predict prognosis.
Jarius, Sven, Wildemann, Brigitte
core +3 more sources
Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases [PDF]
, 2008 Background: Paraneoplastic neurological syndromes (PNS) are indirect remote effects of cancer on the nervous system, often associated with the presence of specific serum antibodies.
Hoffmann, L. A. +10 more
core +1 more source
Paraneoplastic Neuropathies: What's New Since the 2004 Recommended Diagnostic Criteria
Frontiers in Neurology, 2021 The diagnostic criteria published by the PNS (Paraneoplastic Neurological Syndromes) Euronetwork in 2004 provided a useful classification of PNS, including paraneoplastic neuropathies.
Marco Zoccarato +6 more
doaj +1 more source
Diagnosis and treatment of paraneoplastic neurological disorders [PDF]
, 2004 In about two thirds of cases, patients with paraneoplastic neurological disorders present to the neurologist without a known tumor. Due to the ongoing immune response, this tumor tends to stay biologically relatively benign, and therefore difficult to ...
Graus, F., Voltz, R.
core +1 more source
Case Reports in Neurology, 2017 Neurologic symptoms secondary to a paraneoplastic syndrome may be the presenting manifestation of a previously undiagnosed cancer, and alertness to these syndromes may provide an opportunity for early detection and treatment of a cancer.
Ingrid Yang, Joanna Jaros, Danny Bega
doaj +1 more source
Neurological manifestation of cancer – paraneoplastic syndromes
Current Issues in Pharmacy and Medical Sciences, 2021 Neurological paraneoplastic syndromes (NPS) belong to a heterogeneous group of disorders affecting the nervous system. NPS occur as a result of immunological reaction to the tumor. As a result, the isolated syndrome is formed and manifests itself in many
Szklener Katarzyna, Mandziuk Slawomir
doaj +1 more source
Paraneoplastiline sündroom. Haigusjuhtude kirjeldus [PDF]
, 2007 Paraneoplastiline sündroom (PNS) on kasvaja indutseeritud immunoloogiline reaktsioon, mis algselt kujutab organismi kaitsemehhanismi kasvaja vastu, kuid mis tabab n-ö ekslikult närvisüsteemi rakke.
Glükmann, Meeli +3 more
core +2 more sources
Spectrum of Neurologic Complications in Chronic Lymphocytic Leukemia [PDF]
, 2012 Neurologic disease is believed to be an unusual complication during the course of chronic lymphocytic leukemia. Nevertheless, it has already been proven in autopsy series that the incidence of occult nervous system infiltration is much higher than was ...
Lopes Silva, R
core +1 more source